Search Results for: Gamida

More approvals on the way

Posted on January 8, 2023

This article identifies three more Israeli companies that are expected to receive FDA approval for treatments in 2023. They are Gamida Cell (Omidubicel / NiCord – bone marrow transplants); Protalix (PRX-102 – Fabry disease); and BioLineRX (BL-8040 / Motixafortide – … Continue reading →

Posted in Israel's Medical Achievements | Leave a comment

Investment in Israeli startups 28/2/21

Posted on February 28, 2021

CYE raised $120 million; Gamida Cell raised $75 million; Personetics raised $75 million; Pliops raised $65 million; PerimeterX raised $57 million; Lusha raised $40 million; Redefine Meat raised $29 million; Atera raised $25 million; Nanit raised $25 million; EquityBee raised … Continue reading →

Posted in Economy & Business | Leave a comment

Blood cancer treatment trial succeeds

Posted on February 28, 2021

Israel’s Gamida Cell (reported here previously) published the results of its Phase 3 trial of omidubicel (previously NiCord) in blood-based cancer patients. The treatment resulted in faster blood count recovery, fewer bacterial and viral infections, and fewer days in the … Continue reading →

Posted in Israel's Medical Achievements | Leave a comment

Good news for bone-marrow transplants

Posted on May 17, 2020

Israeli biotech Gamida Cell (see here) published positive results in its Phase 3, 50-center trial of NiCord (now called Omidubicel) that aims to increase the success of bone marrow transplants in blood cancer patients. The stem cells were established much … Continue reading →

Posted in Israel's Medical Achievements | Leave a comment

Success in Sickle-Cell Disease trial

Posted on December 11, 2016

Israeli biotech Gamida Cell published positive results in its Phase I/II trial of NiCord, for the treatment of Sickle-Cell Disease (SCD). All the patients that completed the trial were free of SCD symptoms. http://www.globes.co.il/en/article-gamida-reports-positive-nicord-results-1001165382

Posted in Israel's Medical Achievements | Leave a comment

Treatment for Sickle Cell Disease

Posted on September 25, 2016

The first patient with Sickle Cell Disease (SCD) has received a transplant of CordIn from Israeli biotech Gamida Cell.  CordIn is an alternative for patients awaiting a suitable match for bone marrow transplants.  Trials of CordIn are planned for patients … Continue reading →

Posted in Israel's Medical Achievements | Leave a comment

Blood cancer treatment success

Posted on April 17, 2016

Israel’s Gamida Cell reported good results from Duke University trials of its NiCord blood cancer treatment.  Compared with 101 patients receiving ordinary umbilical cord blood, the 18 patients using NiCord had a lower mortality rate, less infections and less time … Continue reading →

Posted in Israel's Medical Achievements | Leave a comment

Global demand for Israeli health tech

Posted on November 1, 2015

Multinationals have recently been investing heavily in Israeli life science companies. They include Boston Scientific into MValve (heart valves), Novartis into Gamida Cell (stem cell therapies) and eHealthVentures into Intendu (brain dysfunction treatment). http://www.starterincubator.com/venture-capital/israeli-health-tech-is-heating-up-with-a-wave-of-interest-from-abroad/

Posted in Economy & Business | Leave a comment

Leukemia treatment gets boost

Posted on January 11, 2015

The US FDA and the European Medicines Agency have awarded Israel’s stem cell therapy developer Gamida Cell orphan status for its NiCord leukemia treatment. NiCord treats acute lymphoblastic leukemia, acute myeloid leukemia, Hodgkin lymphoma and myelodysplastic syndrome. http://www.globes.co.il/en/article-gamida-cell-leukemia-treatment-granted-orphan-drug-status-1000998856

Posted in Israel's Medical Achievements | Leave a comment

The world loves Israeli companies

Posted on August 31, 2014

The BDS thugs will not like this. Israel is the 4th most attractive country for foreign direct investment. Recent $multi-million deals include Gamida Cell (by Novartis), Simbionix (by 3D Systems), ClarityRay (by Yahoo), Lamina (by China’s Catalyst CEL) and VidMind … Continue reading →

Posted in Economy & Business | Leave a comment